3P Biopharmaceuticals and the American biotech company, Zhittya Genesis Medicine (Zhittya), have successfully accomplished the process transfer and GMP supply of FGF-1 candidate.
Read more
In crisis, the nucleus calls antioxidant enzymes to the rescue. The nucleus being metabolically active is a profound paradigm shift with implications for cancer research.
Read more
Han verificado que la función de estos microorganismos se altera según el tipo de aceite que se consume y se relaciona directamente con el síndrome metabólico, un grupo de factores de riesgo para ...
Read more
Javier Sánchez Martín se incorpora a la unidad AGRIENVIRONMENT del CIALE para encontrar y desarrollar variedades de cereales que, dadas sus características genéticas, se pueden adaptar mejor a las...
Read more
Ha comenzado la inscripción en la Fase I del ensayo clínico Tarcidomgen Kimleucel. El candidato a fármaco es un CAR-T anti-CD19, un receptor de antígeno quimérico y el primer candidato en la cart...
Read more
Minoryx Therapeutics today announces the US Food and Drug Administration (FDA) approval of its Phase 3 clinical trial (CALYX) of lead candidate leriglitazone, to treat adult male X-linked Adrenoleukod...
Read more
It has been identified that the cells of some leukemias silence the production of the BCL7A protein, a protein that helps prevent cells from becoming tumorous.
Read more
They will add a new dimension to our microarray service with a diagnostics-oriented platform, while we will continue to offer traditional services with gene expression microarrays for experimental res...
Read more
The US association FARA (Friedreich's Ataxia Research Alliance) has awarded a grant of 85,000 US dollars a project led by Jordi Tamarit Sumalla, professor at the University of Lleida and researcher i...
Read more
It has been published a study that reveals that microtubules, apart from their known structural role in cells, they also exert an active influence on neuronal communication.
Read more
The results of a study show that the action of a molecule (the peptide SS-31) on cell mitochondria decreases the incidence and mortality of this disease.
Read more
The Growth Factors, Nutrients and Cancer group at the Spanish National Cancer Research Center (CNIO), led by Nabil Djouder, have now published a review on the use of diet in cancer treatment in Trends...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
